Fig. 6
From: BCL7A as a novel prognostic biomarker for glioma patients
BCL7A associated with immune cell infiltration in glioma. GO enrichment analysis significantly distributed DEGs into biological process (A), molecular function (B), cellular component categories (C) and KEGG pathways prediction (D). E Gene-set enrichment analysis (GSEA) of BCL7A in GBM. NES, normalized Enrichment score. F Correlation between BCL7A and immune cell infiltration in LGG and GBM according to TIMER. G IHC staining was employed to detect BCL7A expression and MPO in glioma tissues. H Correlation between the BCL7A and MPO immunohistochemistry (IHC) score. Spearman correlation analysis was employed